OS - you were as I recall a long-time holder of Novogen. I’m guessing you lost money on them. Have you forgiven Dr Kelly for the one strategic error he made - which was to switch from intravenous to oral administration in the Phase 3 phenoxodiol trial - or is that why you’re here commenting now on a stock you don’t own?
Ann: FDA grants IND approval to Veyonda, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $9.409K | 87.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49737 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 51289 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |